KIZOO provides mentoring, seed and early-stage financing with a focus on rejuvenation biotech.
Business Model:
Revenue: $14.7M
Employees: 51-200
Address: Amalienbadstraße 41
City: Karlsruhe
State: baden-württemberg
Zip: 76227
Country: DE
KIZOO provides mentoring, seed and early-stage financing with a focus on rejuvenation biotech. Having been entrepreneurs, VCs and mentors in both, high growth tech and biotech companies theirselves for many years with multiple exits and massive value created for the founders, they now bring this experience to the emerging field of rejuvenation biotech - a young industry that will eventually become much bigger than today&s;s largest technology markets. As part of the Forever Healthy Group, they directly support the creation of startups that turn research on the root causes of aging into therapies and services for humans. Forever Healthy&s;s other initiatives include the evaluation of new rejuvenation therapies, evidenced-based curation of the world&s;s cutting-edge medical knowledge, funding research projects on the root causes of aging and hosting the annual Undoing Aging Conference.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2017 | MOQO | Seed Round | - |
7/2015 | Prescreen | Seed Round | - |
4/2011 | Advertory | Seed Round | - |
1/2015 | Oisin Biotechnologies | Seed Round | - |
8/2014 | Mambu | Series A | 2.7M |
10/2019 | MAIA Biotech | Seed Round | 1.5M |
8/2019 | LIfT BioSciences | Series A | 2.4M |
12/2012 | Mambu | Series A | 1.8M |
7/2011 | Pactas GmbH | Seed Round | - |
1/2016 | Mambu | Series B | 8.7M |
3/2021 | Staffbase | Series D | 0 |
11/2012 | Hojoki | Series A | - |
3/2011 | MegaZebra | Series B | - |
11/2011 | tamyca | Series A | - |
6/2019 | Turn.bio | Seed Round | - |
7/2018 | FoxBio | Venture Round | 10M |
7/2008 | Babbel | Seed Round | - |
10/2017 | Elevian | Convertible Note | 2.6M |
6/2018 | Staffbase | Series B | 10M |
3/2013 | Babbel | Series B | 10M |
8/2017 | Antoxerene | Seed Round | 1.5M |
11/2019 | Underdog Pharmaceuticals | Seed Round | 4M |
11/2020 | Elevian | Seed Round | 0 |
8/2014 | Suitepad | Seed Round | - |
7/2019 | Staffbase | Series C | 23M |
1/2021 | Cellvie | Seed | 5M |
8/2017 | AgeX Therapeutics | Venture Round | 0 |
1/2010 | MegaZebra | Series A | - |
1/2011 | Mambu | Seed Round | 821.4k |
10/2022 | Mogling Bio | Seed Round | - |
4/2022 | Elastrin Therapeutics | Venture Round | 10M |
11/2014 | shyftplan | Pre Seed Round | 1.8M |
3/2022 | Revel Pharmaceuticals | Seed | 8.4M |
9/2021 | Underdog Pharmaceuticals | Seed | 10M |
11/2012 | Hipaway | Seed Round | - |
11/2015 | Staffbase | Seed Round | - |
5/2016 | Staffbase | Series A | 2.3M |
10/2020 | Staffbase | Series C | 0 |
9/2017 | shyftplan | Seed Round | 3.6M |
10/2019 | MAIA Biotech | Seed Round | - |
10/2018 | MOQO | Seed Round | - |
5/2017 | CellAge | Seed Round | - |
11/2011 | Hojoki | Seed Round | 620k |
2/2016 | Suitepad | Series A | 3.3M |
3/2016 | Ichor Therapeutics | Seed Round | 1.4M |
3/2021 | Elastrin Therapeutics | Seed Round | 2.5M |
1/2017 | Lysoclear | Seed Round | - |
4/2022 | Elastrin Therapeutics | Venture Round | 0 |
3/2022 | Revel Pharmaceuticals | Seed Round | 0 |
9/2021 | Underdog Pharmaceuticals | Seed Round | 0 |
3/2021 | Staffbase | Series D | 0 |
3/2021 | Elastrin Therapeutics | Seed Round | 0 |
1/2021 | Cellvie | Seed Round | 0 |
11/2020 | Elevian | Seed Round | 0 |
10/2020 | Staffbase | Series C | 0 |
11/2019 | Underdog Pharmaceuticals | Seed Round | 0 |
10/2019 | MAIA Biotech | Seed Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|